The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Inhibrx Biosciences, Inc. | COM | 45720N103 | 16,523,604 | 1,157,926 | SH | SOLE | 1,157,926 | 0 | 0 | ||
| LAVA Therapeutics N.V. | SHS | N51517105 | 2,533,681 | 1,919,455 | SH | SOLE | 1,919,455 | 0 | 0 | ||
| MeiraGTx Holdings plc | COM | G59665102 | 79,529,245 | 12,197,737 | SH | SOLE | 12,197,737 | 0 | 0 | ||
| Novavax | COM NEW | 670002401 | 43,347,030 | 6,880,481 | SH | SOLE | 6,880,481 | 0 | 0 | ||
| AnaptysBio | COM | 032724106 | 18,246,557 | 821,917 | SH | SOLE | 821,917 | 0 | 0 | ||
| IGM Biosciences | COM | 449585108 | 1,611,652 | 1,438,975 | SH | SOLE | 1,438,975 | 0 | 0 | ||
| Eledon | COM | 28617K101 | 2,208,596 | 814,980 | SH | SOLE | 814,980 | 0 | 0 | ||
| Inozyme, Inc | COM | 45790W108 | 1,773,020 | 443,255 | SH | SOLE | 443,255 | 0 | 0 | ||
| Q32 Bio Inc. | COM | 746964105 | 363,684 | 244,083 | SH | SOLE | 244,083 | 0 | 0 | ||
| Omada Health Inc. | COM | 68170A108 | 9,605,725 | 524,903 | SH | SOLE | 524,903 | 0 | 0 | ||